Rare diseases
Investigational molecules
Locations
Via Franco Gallini 2, 33081 Aviano, Italy
Centro Di Riferimento Oncologico Di Aviano in Aviano, Italy specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer metastatic, Breast cancer, Breast cancer metastatic, and other specialisations. This site conducts important research.
The site conducts extensive research on solid tumors, targeting a broad spectrum of cancers.
Trials aim to evaluate novel targeted therapies and immunotherapy regimens to improve survival.
Investigations focus on hematologic malignancies including leukemia and lymphoma.
Studies assess the efficacy of new cell‑based immunotherapies and combination regimens.
Research addresses lung cancers and related thoracic conditions.
Goals include testing innovative immuno‑oncology agents and precision‑medicine approaches.
Clinical work explores gastro‑intestinal malignancies across the digestive tract.
Efforts seek to improve treatment sequencing and biomarker‑driven therapies.
Studies concentrate on gynecologic cancers affecting women.
Trials evaluate new hormone‑targeted and immunotherapeutic options.
The department investigates bone and soft‑tissue sarcomas.
Research aims to determine the benefit of targeted kinase inhibitors in sarcoma care.
Projects include metabolic profiling in cancer patients, focusing on nutritional status.
Objectives are to refine supportive care strategies that enhance outcomes.
Research covers melanoma and cutaneous tumors.
Studies aim to validate immune checkpoint inhibitors and combination approaches.
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
ItalyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
ItalyA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
ItalyA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
ItalyA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
ItalyStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
ItalyStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients
ItalyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
ItalyRinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer
ItalyRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
ItalyStudy of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer
ItalyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
